|
Post by biotec on Nov 7, 2013 17:49:00 GMT -5
VALENCIA, Calif.--(BUSINESS WIRE)-- MannKind Corporation (MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 14, 2013 at 11:30 AM (ET) at the Westin Grand Central in New York City. Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at www.mannkindcorp.com.
|
|
|
Post by MnkdMainer (MM) on Nov 7, 2013 21:50:02 GMT -5
Strange, given this portion of the 11/4 conference call:
"Steve Byrne - Bank of America Okay. That helps. Do you expect to have any of the 171 and 175 data presented at medical conference prior to your PDUFA date?
"Alfred Mann - Chairman of the Board, Chief Executive Officer I don't know whether the ACE maybe meeting prior to a PDUFA date because the ADA, FDA of course is following the PDUFA date, so there maybe a couple of medical meetings, but I don't have the timing of those meetings in my head at this point in time."
[Note: Hakan was speaking here, not Al.]
I would say the upcoming presentation on 11/14 should be encompassed by the phrase "medical conference," although, strictly speaking, perhaps not.
|
|